This year, ChEM-H named one new doctoral fellow and one honorary fellow.
ChEM-H faculty fellow Polly Fordyce discusses her recent paper published in PNAS. Co-authors include ChEM-H postdoc mentor and undergraduate scholar pair, Daniel Le and Allison Keys, and CBI graduate student, Arjun Aditham.
Stanford ChEM-H co-director Carolyn Bertozzi has been elected as one of this year’s ten new Foreign Members to the Royal Society for her pioneering work in the field of bioorthogonal chemistry.
Stanford ChEM-H co-director Chaitan Khosla's new research on celiac disease is highlighted in Science Daily.
Stanford ChEM-H faculty fellow Stanley Qi and his team used gene-editing techniques to create human immune cells that target and kill cancerous cells, such as leukemia. The approach could be adapted to an array of diseases ranging from solid tumors to neurological and autoimmune disorders.
Stanford and Takeda Pharmaceuticals have formed the Alliance for Innovative Medicines, which will help transform Stanford research into next-generation treatments for disease. Stanford ChEM-H will manage the new collaborative program.
Stanford ChEM-H is hiring new faculty whose research bridges chemistry, engineering and medicine to build a community of scientists who will drive the engineering of molecules, materials, and measurement tools that help understand humans and treat disease.
Jonathan Long joined Stanford ChEM-H as assistant professor of pathology
Michael Fischbach joined Stanford ChEM-H as associate professor of bioengineering
Lingyin Li joined Stanford ChEM-H as assistant professor of biochemistry
Lei Stanley Qi joined Stanford ChEM-H as assistant professor of bioengineering and of chemical and systems biology
Polly Fordyce joined Stanford ChEM-H as assistant professor of genetics.
Carolyn Bertozzi joined Stanford ChEM-H as professor of chemistry and, by courtesy, of chemical and systems biology.
Peter Kim joined Stanford ChEM-H as professor of biochemistry